Neuroimmunology Unit, European Centre for Brain Research, Santa Lucia Foundation, Rome, Italy.
Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4):1043-50. doi: 10.1177/039463200902200420.
There is evidence that in the acute axonal motor neuropathy (AMAN) subtype of Guillain-Barré syndrome antibodies to gangliosides, produced through molecular mimicry by antecedent Campylobacter jejuni (C. jejuni) infection, attack gangliosides expressed in human peripheral nerve axolemma, inducing a primary axonal damage. The aim of this study is to investigate whether the T cell response has a role in AMAN pathogenesis. We isolated monocytes from 4 healthy subjects and 5 AMAN patients with antecedent C. jejuni infection and antibodies to GM1 and/or GD1a gangliosides. Immature dendritic cells expressing CD1 molecules cultured with autologous T cells were stimulated with 2 lipopolysaccharides (LPSs) extracted from C. jejuni strains containing GM1 and GD1a-like structures and with GM1 and GD1a. The T cell response to LPSs and to gangliosides was determined by measuring the release of IFN-gamma and TNF-alpha. We observed a T cell response to both LPSs in controls and AMAN patients, whereas only AMAN patients showed T cell reactivity to gangliosides GM1 and GD1a with a tight correlation between T cell reactivity to the ganglioside and individual antibody responses to the same ganglioside. T cells responding to gangliosides were CD1c-restricted CD8 positive and CD27 negative. These findings indicate a contribution of cellular immunity in the pathogenesis of AMAN. A possible role for ganglioside-reactive T cells might be to facilitate the production of antibodies against gangliosides.
有证据表明,在吉兰-巴雷综合征的急性轴索性运动神经病(AMAN)亚型中,通过先前的空肠弯曲菌(C. jejuni)感染引起的分子模拟产生的针对神经节苷脂的抗体攻击人周围神经轴突膜上表达的神经节苷脂,诱导原发性轴索损伤。本研究旨在探讨 T 细胞反应是否在 AMAN 发病机制中起作用。我们从 4 名健康受试者和 5 名先前感染 C. jejuni 且具有 GM1 和/或 GD1a 神经节苷脂抗体的 AMAN 患者中分离单核细胞。用自体 T 细胞培养表达 CD1 分子的未成熟树突状细胞,用含有 GM1 和 GD1a 样结构的 2 种来自 C. jejuni 菌株的脂多糖(LPS)和 GM1 和 GD1a 刺激这些细胞。通过测量 IFN-γ和 TNF-α的释放来确定 T 细胞对 LPS 和神经节苷脂的反应。我们观察到对照者和 AMAN 患者对 LPS 均有 T 细胞反应,而只有 AMAN 患者对神经节苷脂 GM1 和 GD1a 显示 T 细胞反应,并且 T 细胞对神经节苷脂的反应与针对同一神经节苷脂的个体抗体反应之间存在紧密相关性。对神经节苷脂产生反应的 T 细胞是 CD1c 限制性 CD8 阳性和 CD27 阴性。这些发现表明细胞免疫在 AMAN 的发病机制中起作用。神经节苷脂反应性 T 细胞可能具有促进针对神经节苷脂的抗体产生的作用。